Role of streptococcal infection in the etiopathogenesis of pityriasis lichenoides chronica and the therapeutic efficacy of azithromycin: a randomized controlled trial

Amira Elbendary, Randa Youssef, Mona R E Abdel-Halim, Dalia Abdel Halim, Dina Ahmed El Sharkawy, Mostafa Alfishawy, Maha A Gad, Abdallah Gad, Maha Fathy Elmasry, Amira Elbendary, Randa Youssef, Mona R E Abdel-Halim, Dalia Abdel Halim, Dina Ahmed El Sharkawy, Mostafa Alfishawy, Maha A Gad, Abdallah Gad, Maha Fathy Elmasry

Abstract

The exact aetiology of pityriasis lichenoides chronica (PLC) remains unknown. While phototherapy is the most investigated therapeutic modality, azithromycin has been used scarcely. The aim of this study is to evaluate the therapeutic efficacy of azithromycin in the treatment of PLC compared to NB-UVB and evaluating the presence of streptococcal infection as a possible etiological factor in PLC patients. The study was designed as a randomised controlled trial. Twenty-four patients with PLC were randomly allocated into either azithromycin (n = 13, standard dose every 10 days) or NB-UVB (n = 11, thrice weekly) groups. End of study (EOS) was either complete clearance of lesions or a maximum of 8 weeks. Therapeutic efficacy was defined as percent reduction in lesions and was calculated for the rash as a whole, erythematous papules alone, and hypopigmented lesions alone and graded into complete, very-good, good, poor or no response. Anti-streptolysin O titre (ASOT), anti-deoxyribonuclease B titre (anti-DNaseB) and throat culture were evaluated at day 0. No significant difference existed between both groups as regards therapeutic efficacy. At EOS, NB-UVB achieved significantly more percent reduction in the extent of hypopigmented lesions and consequently in the rash as a whole (p = 0.001, p = 0.034, respectively). The extent of the rash as a whole was significantly less in the NB-UVB at EOS (p = 0.029, respectively). The effect of NB-UVB on hypopigmented lesions appeared early at week 4 of treatment. Only two patients, one from each group, relapsed during the 3 month follow-up. Evidence of recent streptococcal infection was present in 79% of the cases, mainly in the form of elevated ASOT (94.7%). It was significantly more encountered in young children (< 13 years) (p = 0.03) and was associated with more extent of erythematous papules and consequently with more extent of the rash as a whole (p = 0.05 and p = 0.01, respectively). It did not affect outcome of therapy at EOS. Azithromycin did not show more favorable response in patients with recent streptococcal infection. Therapeutic efficacy of azithromycin is comparable to NB-UVB in treatment of PLC; however, NB-UVB is superior in management of hypopigmented lesions. It is highly suggested that PLC could be a post streptococcal immune mediated disorder.Registration number: ClinicalTrials.gov, NCT03831269.

Keywords: ASOT; Azithromycin; Hypopigmented; NB-UVB; Pityriasis lichenoides chronica; Randomized controlled trial; Streptococcal infection.

Conflict of interest statement

The authors declare that they have no conflict of interest.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Patient flow chart demonstrating the sequence of the study according to CONSORT guidelines for reporting randomized controlled trials
Fig. 2
Fig. 2
Biweekly follow-up for percent reduction in the hypopigmented lesions and the rash as a whole in azithromycin and NB-UVB groups
Fig. 3
Fig. 3
Three month follow-up for patients in the azithromycin and NB-UVB groups after EOS

References

    1. Bowers S, Warshaw EM. Pityriasis lichenoides and its subtypes. J Am Acad Dermatol. 2006;55(4):557–576. doi: 10.1016/j.jaad.2005.07.058.
    1. Clayton R, Warin A. Pityriasis lichenoides chronica presenting as hypopigmentation. Br J Dermatol. 1979;100(3):297–302. doi: 10.1111/j.1365-2133.1979.tb06202.x.
    1. Lane TN, Parker SS. Pityriasis lichenoides chronica in black patients. Cutis. 2010;85(3):125–129.
    1. Hapa A, Ersoy-Evans S, Karaduman A. Childhood pityriasis lichenoides and oral erythromycin. Pediatr Dermatol. 2012;29(6):719–724. doi: 10.1111/j.1525-1470.2012.01765.x.
    1. Geller L, Antonov NK, Lauren CT, Morel KD, Garzon MC. Pityriasis Lichenoides in Childhood: Review of Clinical Presentation and Treatment Options. Pediatr Dermatol. 2015;32(5):579–592. doi: 10.1111/pde.12581.
    1. Dupont C. Pityriasis lichenoides in a family. Br J Dermatol. 1995;133(2):338–339. doi: 10.1111/j.1365-2133.1995.tb02650.x.
    1. Ersoy-Evans S, Greco MF, Mancini AJ, Subaşi N, Paller AS. Pityriasis lichenoides in childhood: a retrospective review of 124 patients. J Am Acad Dermatol. 2007;56(2):205–210. doi: 10.1016/j.jaad.2006.08.023.
    1. Aydogan K, Saricaoglu H, Turan H. Narrowband UVB (311 nm, TL01) phototherapy for pityriasis lichenoides. Photodermatol Photoimmunol Photomed. 2008;24(3):128–133. doi: 10.1111/j.1600-0781.2008.00350.x.
    1. Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2009;119(11):1541–1551. doi: 10.1161/CIRCULATIONAHA.109.191959.
    1. Heritier SR, Gebski VJ, Keech AC. Inclusion of patients in clinical trial analysis: the intention-to-treat principle. Med J Aust. 2003;179(8):438–440. doi: 10.5694/j.1326-5377.2003.tb05627.x.
    1. Skinner RB, Levy AL. Rapid resolution of pityriasis lichenoides et varioliformis acuta with azithromycin. J Am Acad Dermatol. 2008;58(3):524–525. doi: 10.1016/j.jaad.2006.07.031.
    1. Di Costanzo L, Balato N, La Bella S, Balato A. Successful association in the treatment of pityriasis lichenoides et varioliformis acuta. J Eur Acad Dermatol Venereol. 2009;23(8):971–972. doi: 10.1111/j.1468-3083.2008.03077.x.
    1. Ogrum A, Takci Z, Seckin HY, Cetin E. A case of pityriasis lichenoides: Rapid resolution with azithromycin monotherapy in 3 weeks. Dermatol Ther. 2018;31(5):e12681. doi: 10.1111/dth.12681.
    1. Feola H, Mancinelli MC, Perez-Klala MV, Verea MA. Pityriasis lichenoides chronica: Rapid response after a single cycle of azithromycin therapy. Dermatol Ther. 2020;33(3):e13303. doi: 10.1111/dth.13303.
    1. Bellinato F, Maurelli M, Gisondi P, Girolomoni G. A systematic review of treatments for pityriasis lichenoides. J Eur Acad Dermatol Venereol. 2019;33(11):2039–2049. doi: 10.1111/jdv.15813.
    1. Fernández-Guarino M, Aboin-Gonzalez S, Ciudad Blanco C, Velázquez Tarjuelo D, Lázaro OP. Treatment of adult diffuse pityriasis lichenoides chronica with narrowband ultraviolet B: experience and literature review. Clin Exp Dermatol. 2017;42(3):303–305. doi: 10.1111/ced.13035.
    1. Kotby AA, Habeeb NM, Ezz El Elarab S. Antistreptolysin O titer in health and disease: levels and significance. Pediatr Rep. 2012;4(1):e8. doi:10.4081/pr.2012.e8
    1. Robson WL, Leung AK. Post-streptococcal glomerulonephritis: Recent increase of incidence in southern Alberta. Can Fam Physician. 1992;38:2883–2887.
    1. Eisenstein EM, Navon-Elkan P. Acute rheumatic fever associated with Henoch-Schönlein purpura: report of three cases and review of the literature. Acta Paediatr. 2002;91(11):1265–1267. doi: 10.1080/080352502320777559.
    1. Leung TN, Hon KL, Leung AK. Group A Streptococcus disease in Hong Kong children: an overview. Hong Kong Med J. 2018;24(6):593–601. doi: 10.12809/hkmj187275.
    1. Takahashi K, Atsumi M. Pityriasis lichenoides chronica resolving after tonsillectomy. Br J Dermatol. 1993;129(3):353–354. doi: 10.1111/j.1365-2133.1993.tb11872.x.
    1. English JC, 3rd, Collins M, Bryant-Bruce C. Pityriasis lichenoides et varioliformis acuta and group-A beta hemolytic streptococcal infection. Int J Dermatol. 1995;34(9):642–644. doi: 10.1111/j.1365-4362.1995.tb01097.x.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner